Chemoinformaics analysis of ALPHA-RESORCYLIC-ACID
| Molecular Weight | 496.913 | nRot | 6 |
| Heavy Atom Molecular Weight | 448.529 | nRig | 7 |
| Exact Molecular Weight | 496.286 | nRing | 1 |
| Solubility: LogS | -7.345 | nHRing | 0 |
| Solubility: LogP | 7.835 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 80 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 32 | No. of Aromatic Carbocycles | 1 |
| nHetero | 7 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 48 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 25 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 6 |
| nHA | 4 | APOL | 93.5541 |
| nHD | 0 | BPOL | 100.55 |
| QED | 0.37 |
| Synth | 2.932 |
| Natural Product Likeliness | -0.113 |
| NR-PPAR-gamma | 0.015 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.946 |
| Pgp-sub | 0.003 |
| HIA | 0.984 |
| CACO-2 | -5.723 |
| MDCK | 0.0000131 |
| BBB | 0 |
| PPB | 1.09714 |
| VDSS | 6.67 |
| FU | 0.00472348 |
| CYP1A2-inh | 0.203 |
| CYP1A2-sub | 0.958 |
| CYP2c19-inh | 0.733 |
| CYP2c19-sub | 0.915 |
| CYP2c9-inh | 0.745 |
| CYP2c9-sub | 0.878 |
| CYP2d6-inh | 0.087 |
| CYP2d6-sub | 0.877 |
| CYP3a4-inh | 0.762 |
| CYP3a4-sub | 0.267 |
| CL | 3.237 |
| T12 | 0.684 |
| hERG | 0.006 |
| Ames | 0.009 |
| ROA | 0.05 |
| SkinSen | 0.04 |
| Carcinogencity | 0.007 |
| EI | 0.989 |
| Respiratory | 0.352 |
| NR-Aromatase | 0.099 |
| Antiviral | Yes |
| Prediction | 0.539957 |